Current Cancer Drug Targets

Papers
(The H4-Index of Current Cancer Drug Targets is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
A Pilot Study of Anlotinib as a Combination Treatment in Advanced Nasopharyngeal Carcinoma49
Case Report and Literature Review of Multi-drugs Synergy and Targeted Comprehensive Treatment in Advanced Hepatocellular Carcinoma27
Experimental Determination of Cancer Drug Targets with Independent Mechanisms of Resistance26
Artificial Intelligence (AI) and Liquid Biopsy Transforming Early Detection of Liver Metastases in Gastrointestinal Cancers24
Efficacy and Safety of Immunotherapy Combined with Anlotinib as FirstLine Treatment in Older NSCLC Patients with PD-L1 Expression<50%22
Engineering Pancreatic Organoids22
TCF19 Enhances Glioma Cell Proliferation via Modulating the Β-Catenin Signaling Pathway through Accelerating DHX32 Transcription21
Clinical Significance of HHLA2 as a Novel Therapeutic Target for Colorectal Cancer19
Computational Design for Identification of Human Anti-MUC1 Heteroclitic Peptides in the Treatment of HER2-Positive Breast Cancer through Neural Network Training and Monomeric based Design19
The Plasticity of Circulating Tumor Cells in Ovarian Cancer During Platinum-containing Chemotherapy17
Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway16
Gastroenteropancreatic Neuroendocrine Neoplasms (GEP NENs): The Role of Checkpoint Inhibitors15
The Pattern of Anemia in Pediatric Solid Tumors Prior to and after Chemotherapy- A Retrospective Cohort Study15
New Progress on DNA Primase Subunit Enzymes Research and Link to Cancer Development and Treatment Approaches15
Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators14
0.10591220855713